Health - Google News: Oncolytics lung cancer drug meets main goal in mid-stage trial - Reuters

Health - Google News Google News

Oncolytics lung cancer drug meets main goal in mid-stage trial - Reuters Sep 13th 2012, 12:15 Proactive Investors USA & Canada Oncolytics lung cancer drug meets main goal in mid-stage trial Reuters (Reuters) - Oncolytics Biotech Inc said the first part of a mid-stage trial of its lung cancer drug met the main goal of showing patient response. The US mid-stage trial, which is divided into two parts, is testing Oncolytics's Reolysin in combination ... Oncolytics Meets Primary Endpoint For First Stage Of Phase 2 Lung Cancer TrialNASDAQ Oncolytics Biotech Inc. Provides Update on Phase III Study of REOLYSIN® in ...Sacramento Bee Oncolytics' shares plunge as it expands cancer drug trialProactive Investors USA & Canada Benzinga all 43 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: